Considering that TGF-β is widely involved in trabecular meshwork sclerosis and in fibrotic phase of POAG [32,33,34], and that it has already been proposed as a potential therapeutic target [31], the description of such PML-TGF- β axis may help in highlighting new putative pharmacological targets for POAG treatment. This evidence concerns the gene PML and open-angle glaucoma.